NCT00045747View on ClinicalTrials.gov

UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2002

Study Completion Date

September 30, 2004

Conditions
Pancreatic Cancer
Interventions
DRUG

7-hydroxystaurosporine

DRUG

fluorouracil

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00045747 - UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter